Kefeng Wang

1.3k total citations
41 papers, 896 citations indexed

About

Kefeng Wang is a scholar working on Epidemiology, Oncology and Rehabilitation. According to data from OpenAlex, Kefeng Wang has authored 41 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 10 papers in Oncology and 9 papers in Rehabilitation. Recurrent topics in Kefeng Wang's work include Acute Ischemic Stroke Management (15 papers), Stroke Rehabilitation and Recovery (9 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Kefeng Wang is often cited by papers focused on Acute Ischemic Stroke Management (15 papers), Stroke Rehabilitation and Recovery (9 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Kefeng Wang collaborates with scholars based in China, United States and Italy. Kefeng Wang's co-authors include Xiaonan Chen, Liang Wang, Zhongjun Xia, Yunfei Xia, Zhi‐Hui Wang, Xia Wang, Shijie Li, Bin Wu, Chuanhui Dong and José G. Romano and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

Kefeng Wang

40 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kefeng Wang China 19 301 238 237 200 190 41 896
Kyoung Ha Kim South Korea 17 325 1.1× 163 0.7× 199 0.8× 97 0.5× 111 0.6× 72 932
Emanuele Naglieri Italy 15 336 1.1× 77 0.3× 210 0.9× 95 0.5× 141 0.7× 42 1.0k
Hamed Daw United States 18 380 1.3× 179 0.8× 129 0.5× 118 0.6× 118 0.6× 99 954
Laura Visa Spain 15 662 2.2× 220 0.9× 180 0.8× 70 0.3× 334 1.8× 37 1.0k
Steven Andrèsen United States 16 347 1.2× 205 0.9× 211 0.9× 47 0.2× 51 0.3× 48 915
Yun‐Gyoo Lee South Korea 15 436 1.4× 78 0.3× 233 1.0× 41 0.2× 123 0.6× 72 942
Matteo Brighenti Italy 12 628 2.1× 47 0.2× 182 0.8× 137 0.7× 63 0.3× 38 869
Ignacio Escobar Spain 17 243 0.8× 80 0.3× 165 0.7× 41 0.2× 92 0.5× 63 950
Joel Baumgartner United States 19 360 1.2× 84 0.4× 87 0.4× 80 0.4× 179 0.9× 56 1.1k
Renata D’Alpino Peixoto Brazil 17 569 1.9× 81 0.3× 119 0.5× 221 1.1× 164 0.9× 95 964

Countries citing papers authored by Kefeng Wang

Since Specialization
Citations

This map shows the geographic impact of Kefeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Wang more than expected).

Fields of papers citing papers by Kefeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Wang. The network helps show where Kefeng Wang may publish in the future.

Co-authorship network of co-authors of Kefeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kefeng Wang. A scholar is included among the top collaborators of Kefeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefeng Wang. Kefeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Voso, Maria Teresa, Stéphane de Botton, Michael Pfeilstöcker, et al.. (2024). A post-hoc analysis of outcomes of patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) who received oral azacitidine (Oral-AZA) maintenance therapy in the QUAZAR AML-001 study.. Journal of Clinical Oncology. 42(16_suppl). 6522–6522. 1 indexed citations
3.
Perue, Gillian Gordon, Hao Ying, Lili Zhou, et al.. (2023). A 10-year review of antihypertensive prescribing practices after stroke and the associated disparities from the Florida Stroke Registry. medRxiv. 1 indexed citations
4.
Wang, Kexi, Jing Huang, Xuan Xie, et al.. (2023). A propensity score–matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma. Journal of Surgical Oncology. 128(2). 207–217. 6 indexed citations
5.
Ravandi, Farhad, Hartmut Döhner, Andrew H. Wei, et al.. (2023). Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001. British Journal of Haematology. 204(3). 877–886. 2 indexed citations
6.
Wang, Yuan, et al.. (2023). Knowledge-map analysis of percutaneous nephrolithotomy (PNL) for urolithiasis. Urolithiasis. 51(1). 34–34. 4 indexed citations
7.
Li, Mingyang, Lei Li, Jianyi Zheng, et al.. (2023). Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. Molecular Cancer. 22(1). 37–37. 44 indexed citations
8.
Wang, Xia, et al.. (2022). The global status of research in prostate cancer bone metastasis: A bibliometric and visualized analysis. Frontiers in Medicine. 9. 931422–931422. 9 indexed citations
9.
Perez, Enmanuel J., Kefeng Wang, Carolina M Gutierrez, et al.. (2021). Sex and Race‐Ethnic Disparities in Door‐to‐CT Time in Acute Ischemic Stroke: The Florida Stroke Registry. Journal of the American Heart Association. 10(7). e017543–e017543. 17 indexed citations
10.
Chen, Xiaonan, Yiqiao Zhao, Zijia Tao, & Kefeng Wang. (2021). Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis. BMJ Open. 11(2). e038902–e038902. 26 indexed citations
11.
Gardener, Hannah, Tatjana Rundek, Judith H. Lichtman, et al.. (2021). Adherence to Acute Care Measures Affects Mortality in Patients with Ischemic Stroke: The Florida Stroke Registry. Journal of Stroke and Cerebrovascular Diseases. 30(3). 105586–105586. 4 indexed citations
12.
Dong, Chuanhui, Kefeng Wang, Marco R. Di Tullio, et al.. (2019). Disparities and Temporal Trends in Stroke Care Outcomes in Patients with Atrial Fibrillation: The FLiPER-AF Stroke Study. PubMed. 2(2). 4 indexed citations
13.
Liu, Panpan, Kefeng Wang, Jietian Jin, et al.. (2018). Role of radiation therapy in primary breast diffuse large B‐cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Medicine. 7(5). 1845–1851. 12 indexed citations
14.
Wang, Kefeng, et al.. (2017). miR-211-5p Suppresses Metastatic Behavior by Targeting SNAI1 in Renal Cancer. Molecular Cancer Research. 15(4). 448–456. 41 indexed citations
15.
Gardener, Hannah, Kefeng Wang, Chuanhui Dong, et al.. (2017). Stroke Hospital Characteristics in the Florida–Puerto Rico Collaboration to Reduce Stroke Disparities Study. Southern Medical Journal. 110(7). 466–474. 6 indexed citations
16.
Wang, Kefeng, Wenjun He, Yi Xia, et al.. (2017). Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study. Journal of Cancer. 8(14). 2676–2683. 6 indexed citations
17.
Chen, Xiaonan, Shijie Li, Zhenqun Xu, et al.. (2015). Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience. World Journal of Surgical Oncology. 13(1). 14–14. 26 indexed citations
18.
Wang, Kefeng, et al.. (2015). Once-weekly Subcutaneous Administration of Bortezomib in Patients with Multiple Myeloma. Asian Pacific Journal of Cancer Prevention. 16(5). 2093–2098. 12 indexed citations
19.
20.
Cai, Dawei, Xuefeng Liu, Renge Bu, et al.. (2010). Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population. Journal of Genetics. 89(2). 263–267. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyoung Ha Kim Breakdown of academic impact, for papers by Emanuele Naglieri Breakdown of academic impact, for papers by Hamed Daw Breakdown of academic impact, for papers by Laura Visa Breakdown of academic impact, for papers by Steven Andrèsen Breakdown of academic impact, for papers by Yun‐Gyoo Lee Breakdown of academic impact, for papers by Matteo Brighenti Breakdown of academic impact, for papers by Ignacio Escobar Breakdown of academic impact, for papers by Joel Baumgartner Breakdown of academic impact, for papers by Renata D’Alpino Peixoto
Rankless by CCL
2026